Trial Information
Disease	Prostate cancer
Stage of disease/treatment	Non-metastatic, castration resistant prostate cancer
Prior therapy	Previous anti-androgen was allowed, androgen deprivation therapy was required.
Type of study	Randomized phase II
Primary endpoint	Time to treatment failure
Secondary endpoints	Immune responses PSA responses
Investigator’s analysis	Inactive because results did not meet primary endpoint